@article{3cb48b3b8df3421c9f4326516a62b051,
title = "Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP.",
keywords = "B-CELL LYMPHOMA, NON-HODGKINS-LYMPHOMA, ELDERLY-PATIENTS, RISK-FACTORS, AGGRESSIVE LYMPHOMA, CNS PROPHYLAXIS, RITUXIMAB, MULTICENTER, IMPACT",
author = "Sophie Bernard and Herve Ghesquieres and Rene-Olivier Casasnovas and Samuel Griolet and {Gomes da Silva}, Maria and Pierre Feugier and Franck Morschhauser and Judith Trotman and Loic Renaud and Richard Greil and Garc{\'i}a-Sancho, {Alejandro Mart{\'i}n} and Sebastian Grosicki and {van Eygen}, Koen and Christiane Copie-Bergman and Corinne Haioun and Catherine Thieblemont",
note = "Greil: Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute, Center for Clinical Cancer and Immunology Trials, Cancer Cluster Salzburg, Salzburg, Austria;",
year = "2021",
doi = "10.1182/bloodadvances.2021004766",
language = "English",
volume = "5",
pages = "2965--2968",
journal = "BLOOD ADVANCES",
issn = "2473-9529",
number = "15",
}